PRCT
Income statement / Annual
Last year (2024), PROCEPT BioRobotics Corporation's total revenue was $224.50 M,
an increase of 64.84% from the previous year.
In 2024, PROCEPT BioRobotics Corporation's net income was -$91.41 M.
See PROCEPT BioRobotics Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$224.50 M |
$136.19 M |
$75.01 M |
$34.47 M |
$7.72 M |
$6.17 M |
| Cost of Revenue |
$87.40 M
|
$65.14 M
|
$37.93 M
|
$18.61 M
|
$8.97 M
|
$8.05 M
|
| Gross Profit |
$137.10 M
|
$71.05 M
|
$37.09 M
|
$15.87 M
|
-$1.26 M
|
-$1.89 M
|
| Gross Profit Ratio |
0.61
|
0.52
|
0.49
|
0.46
|
-0.16
|
-0.31
|
| Research and Development Expenses |
$62.30 M
|
$48.45 M
|
$28.98 M
|
$18.99 M
|
$16.28 M
|
$13.15 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$171.42 M
|
$131.77 M
|
$88.83 M
|
$51.04 M
|
$30.27 M
|
$28.52 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$233.71 M
|
$180.22 M
|
$117.81 M
|
$70.03 M
|
$46.55 M
|
$41.67 M
|
| Cost And Expenses |
$321.11 M
|
$245.36 M
|
$155.74 M
|
$88.64 M
|
$55.52 M
|
$49.72 M
|
| Interest Income |
$10.90 M
|
$7.55 M
|
$2.50 M
|
$76.00 K
|
$184.00 K
|
$1.15 M
|
| Interest Expense |
$4.18 M
|
$4.00 M
|
$5.18 M
|
$5.81 M
|
$5.26 M
|
$724.00 K
|
| Depreciation & Amortization |
$5.23 M
|
$3.81 M
|
$2.84 M
|
$3.32 M
|
$2.86 M
|
$1.49 M
|
| EBITDA |
-$82.00 M |
-$98.10 M |
-$79.13 M |
-$50.72 M |
-$44.90 M |
-$39.76 M |
| EBITDA Ratio |
-0.37
|
-0.72
|
-1.05
|
-1.47
|
-5.82
|
-6.44
|
| Operating Income Ratio |
-0.43
|
-0.8
|
-1.08
|
-1.57
|
-6.19
|
-7.06
|
| Total Other Income/Expenses Net |
$5.20 M
|
$3.27 M
|
-$6.43 M
|
-$5.69 M
|
-$5.22 M
|
$1.58 M
|
| Income Before Tax |
-$91.41 M
|
-$105.90 M
|
-$87.15 M
|
-$59.85 M
|
-$53.02 M
|
-$41.98 M
|
| Income Before Tax Ratio |
-0.41
|
-0.78
|
-1.16
|
-1.74
|
-6.87
|
-6.8
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$91.41 M
|
-$105.90 M
|
-$87.15 M
|
-$59.85 M
|
-$53.02 M
|
-$41.98 M
|
| Net Income Ratio |
-0.41
|
-0.78
|
-1.16
|
-1.74
|
-6.87
|
-6.8
|
| EPS |
-1.75 |
-2.24 |
-1.96 |
-3.63 |
-1.51 |
-1.25 |
| EPS Diluted |
-1.75 |
-2.24 |
-1.96 |
-3.63 |
-1.51 |
-1.25 |
| Weighted Average Shares Out |
$52.13 M
|
$47.26 M
|
$44.40 M
|
$16.48 M
|
$35.14 M
|
$33.59 M
|
| Weighted Average Shares Out Diluted |
$52.13 M
|
$47.26 M
|
$44.40 M
|
$16.48 M
|
$35.14 M
|
$33.59 M
|
| Link |
|
|
|
|
|
|
